例如:"NBL1", "4681", "drought"
收藏
397357 ADRB2

397357

ADRB2

adrenoceptor beta 2

protein-coding

Sus scrofa

基因描述

Type Description
Definition adrenoceptor beta 2

研究结论

Date Results Publications
2017-05-13 22:04:00 The Galphas and Galphaq peptides adopt different orientations in beta2-AR and V1AR, respectively. The beta2-AR/Galphas peptide interface is dominated by electrostatic interactions, whereas the V1AR/Galphaq peptide interactions are predominantly hydrophobic. 27330078
2015-08-01 10:27:00 A persistent B2R-beta2AR heterodimer was confirmed in bradykinin-stimulated and non-stimulated left ventricular myocardium. BK transactivation of beta2AR enhanced beta2AR-mediated release of tPA. 25078038
2015-02-28 12:05:00 These data collectively reveal the potential of beta2ARag to improve skin scarring. 25050597
2010-04-12 12:17:00 Beta(1)- and beta(2)-adrenoceptors contribute to the beta-feedforward coronary resistance vessel dilation during exercise. 20035031
2010-01-21 00:00:00 Prolactin infusion brought about the inhibition of a vasodilatory beta(2)-adrenergic receptor-mediated effect related to the NO intracellular pathway 17463060

名称对应

Type IDs
Gene
UniProtKB-ID: ADRB2_PIG
UniprotKB: Q28997
UniParc: UPI00001266D1
EMBL: U53185, AF000134, AY526088
KO: ssc:397357
Nucleutide sequences
EMBL-CDS: AAS18308.1, AAB58713.1, AAB01978.1
Protein sequencees
RefSeq: NP_001121908.1, XP_020936817.1
Others
UniRef100: UniRef100_Q28997
UniRef90: UniRef90_Q28997
UniRef50: UniRef50_P10608
UniGene: Ssc.16077

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员